Study on ASTRA TECH Implant System, OsseoSpeed™ Implants in Patients Missing All Teeth in the Upper Jaw, Restored With Provisional Teeth Within 24 Hours
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT00711022 |
|
Recruitment Status :
Completed
First Posted : July 8, 2008
Results First Posted : May 13, 2014
Last Update Posted : July 16, 2014
|
- Study Details
- Tabular View
- Study Results
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Jaw, Edentulous | Device: ASTRA TECH Implant System, OsseoSpeed™, all dimensions. | Not Applicable |
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 51 participants |
| Allocation: | N/A |
| Intervention Model: | Single Group Assignment |
| Masking: | None (Open Label) |
| Primary Purpose: | Treatment |
| Official Title: | An Open, Prospective, Multicenter Study to Evaluate the Outcome of ASTRA TECH Implant System, OsseoSpeed™ Implants, in Patients With Totally Edentulous Maxillas and Poor Bone Quality and Quantity in an Immediate Loading Protocol. |
| Study Start Date : | May 2005 |
| Actual Primary Completion Date : | March 2012 |
| Actual Study Completion Date : | March 2012 |
| Arm | Intervention/treatment |
|---|---|
| Experimental: OsseoSpeed |
Device: ASTRA TECH Implant System, OsseoSpeed™, all dimensions. |
- Implant Survival Rate [ Time Frame: At 5-year follow-up ]An implant that has failed to osseointegrate, lost its osseointegration or fractured was considered a failure effective from the date of removal. The survival rate for individual implants was analyzed at each visit. Cumulative implant survival rate was calculated using Kaplan-Meier life-table estimation and reported as percentage of survived implants.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 20 Years and older (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Provision of informed consent
- Aged 20 years and over
- History of totally edentulous maxilla of at least three months
- Radiographic finding indicating bone quality class 3 or 4 (Lekholm and Zarb) in the maxilla
- Radiographic finding indicating bone quantity class C, D or E (Lekholm and Zarb) in the maxilla
- Presence of natural teeth, partial prosthesis and/or implants in the mandible, within positions 35-45 (according to the FDI digit system)
- Deemed by the investigator as likely to present an initially stable implant situation suitable for immediate loading.
Exclusion Criteria:
- Unlikely to be able to comply with study procedures, as judged by the investigator
- Uncontrolled pathologic processes in the oral cavity
- Known or suspected current malignancy
- History of radiation in the head and neck region
- History of chemotherapy within 5 years prior to surgery
- Systemic or local disease or condition that would compromise post-operative healing and/or osseointegration
- Uncontrolled Diabetes Mellitus
- Corticosteroids or any other medication that would compromise post-operative healing and/or osseointegration
- History of bone augmentation in the maxilla within 6 months prior to surgery
- Known pregnancy at time of enrolment
- Present alcohol and/or drug abuse
- Current use of tobacco or history of tobacco use within 6 months prior to surgery
- Need for interpreter
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00711022
| United States, Illinois | |
| The University of Chicago, MC-2108 | |
| Chicago, Illinois, United States, 60637 | |
| Sweden | |
| Uppsala University Hospital, Dept. of Surgical Sciences, Oral and Maxillofacial Surgery, Faculty of Medicine | |
| Uppsala, Sweden, SE-751 85 | |
| Principal Investigator: | Joseph A Toljanic, Prof. | University of Chicago |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
| Responsible Party: | Dentsply Sirona Implants |
| ClinicalTrials.gov Identifier: | NCT00711022 |
| Other Study ID Numbers: |
YA-OSS-0008 |
| First Posted: | July 8, 2008 Key Record Dates |
| Results First Posted: | May 13, 2014 |
| Last Update Posted: | July 16, 2014 |
| Last Verified: | May 2014 |
|
Jaw, Edentulous (maxilla, with poor bone quality and quantity) |
|
Jaw, Edentulous Mouth, Edentulous Mouth Diseases Stomatognathic Diseases |
Tooth Diseases Jaw Diseases Musculoskeletal Diseases |

